| 摘要 |
The present disclosure provides 2'-C-methyl-ribofuranosyl cytidine prodrugs, methods of making 2'-C-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions of 2'-C-methyl-ribofuranosyl cytidine prodrugs, and methods of using 2'-C-methyl-ribofuranosyl cytidine prodrugs and pharmaceutical compositions thereof to treat viral diseases such as hepatitis C.
|
